drug
FOSAPREPITANT
updated 3mo agoby DR REDDYS
community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying FOSAPREPITANT
- phase2Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
- phase3A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
- phase3To Evaluate the Efficacy and Safety of QLM2010 for Prevention of Chemotherapy-induced Nausea and Vomiting After Highly Emetogenic Chemotherapy.
- phase4Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)
- EP1An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects
- phase3Clinical Study of HR20013 for Injection in Patients With Malignant Solid Tumors
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that